- Home
- PYPL vs HLN Comparison
PYPL vs HLN Comparison
Compare PYPL & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPL
- HLN
- Stock Information
- Founded
- PYPL 1998
- HLN 2022
- Country
- PYPL United States
- HLN United Kingdom
- Employees
- PYPL N/A
- HLN N/A
- Industry
- PYPL Business Services
- HLN Package Goods/Cosmetics
- Sector
- PYPL Consumer Discretionary
- HLN Consumer Discretionary
- Exchange
- PYPL Nasdaq
- HLN Nasdaq
- Market Cap
- PYPL 56.8B
- HLN 45.6B
- IPO Year
- PYPL 2002
- HLN N/A
- Fundamental
- Price
- PYPL $61.00
- HLN $10.22
- Analyst Decision
- PYPL Buy
- HLN Buy
- Analyst Count
- PYPL 34
- HLN 1
- Target Price
- PYPL $86.93
- HLN $10.95
- AVG Volume (30 Days)
- PYPL 12.7M
- HLN 13.6M
- Earning Date
- PYPL 04-29-2025
- HLN 02-27-2025
- Dividend Yield
- PYPL N/A
- HLN 1.65%
- EPS Growth
- PYPL 3.91
- HLN 38.94
- EPS
- PYPL 3.99
- HLN 0.20
- Revenue
- PYPL $31,797,000,000.00
- HLN $14,062,871,660.00
- Revenue This Year
- PYPL $5.73
- HLN $5.66
- Revenue Next Year
- PYPL $6.40
- HLN $4.86
- P/E Ratio
- PYPL $15.29
- HLN $25.21
- Revenue Growth
- PYPL 6.80
- HLN N/A
- 52 Week Low
- PYPL $55.85
- HLN $8.06
- 52 Week High
- PYPL $93.66
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- PYPL 40.61
- HLN 54.81
- Support Level
- PYPL $59.72
- HLN $9.18
- Resistance Level
- PYPL $63.90
- HLN $9.74
- Average True Range (ATR)
- PYPL 3.04
- HLN 0.25
- MACD
- PYPL 0.18
- HLN 0.03
- Stochastic Oscillator
- PYPL 43.94
- HLN 74.55
About PYPL PayPal Holdings Inc.
PayPal was spun off from eBay in 2015 and provides electronic payment solutions to merchants and consumers, with a focus on online transactions. The company had 434 million active accounts at the end of 2024. The company also owns Venmo, a person-to-person payment platform.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.